<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38756213</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in neurology</Title><ISOAbbreviation>Front Neurol</ISOAbbreviation></Journal><ArticleTitle>Transcutaneous vagus nerve stimulation improves Long COVID symptoms in a female cohort: a pilot study.</ArticleTitle><Pagination><StartPage>1393371</StartPage><MedlinePgn>1393371</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1393371</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2024.1393371</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Long COVID, also known as Post-COVID-19 syndrome, is characterized by multisystemic symptoms that persists for weeks to years beyond acute infection. It disproportionately affects women and those with pre-existing anxiety/depression, conditions more prevalent in females. The vagus nerve, with its extensive innervation and regulation of critical bodily functions, has become a focal point for therapeutic interventions. Transcutaneous vagus nerve stimulation (t-VNS) has emerged as a promising non-invasive treatment for COVID-19 conditions.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This pilot study assessed the efficacy of t-VNS in 24 female Long COVID patients (45.8&#x2009;&#xb1;&#x2009;11.7&#x2009;years old; 20.2&#x2009;&#xb1;&#x2009;7.1&#x2009;months since infection), who underwent a 10-day&#x2009;t-VNS intervention at home (30&#x2009;min/session, twice a day). Cognition was considered the primary outcome, with anxiety, depression, sleep, fatigue, and smell as secondary outcomes. Outcomes were measured at baseline, post-intervention, and 1-month follow-up.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Significant improvements were observed in various cognitive functions, anxiety, depression, and sleep at post-intervention, with benefits remaining or progressing at 1-month follow-up. Improvements in fatigue were delayed, reaching statistical significance at 1-month follow-up compared to baseline. No significant changes were noted in olfactory performance.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">This pilot study provides preliminary evidence supporting the potential of t-VNS as a therapeutic intervention for female Long COVID patients. The encouraging results justify further rigorous investigation through larger, randomized controlled trials to confirm the efficacy of t-VNS, assess its generalizability to male cohorts, and explore biological markers to inform personalized treatment approaches. Our findings support the allocation of resources to conduct such trials and advance the understanding of t-VNS as a potential treatment for Long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Zheng, Simonian, Wang and Rosario.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Zhong Sheng</ForeName><Initials>ZS</Initials><AffiliationInfo><Affiliation>Research Institute, Casa Colina Hospital and Centers for Healthcare, Pomona, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simonian</LastName><ForeName>Ninette</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Advanced Consciousness Studies, Santa Monica, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Research Institute, Casa Colina Hospital and Centers for Healthcare, Pomona, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosario</LastName><ForeName>Emily R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Research Institute, Casa Colina Hospital and Centers for Healthcare, Pomona, CA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurol</MedlineTA><NlmUniqueID>101546899</NlmUniqueID><ISSNLinking>1664-2295</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">female health</Keyword><Keyword MajorTopicYN="N">mood and cognition</Keyword><Keyword MajorTopicYN="N">neuromodulation</Keyword><Keyword MajorTopicYN="N">sleep</Keyword><Keyword MajorTopicYN="N">transcutaneous vagus nerve stimulation (t-VNS)</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>17</Day><Hour>3</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38756213</ArticleId><ArticleId IdType="pmc">PMC11097097</ArticleId><ArticleId IdType="doi">10.3389/fneur.2024.1393371</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, WHO Clinical Case Definition Working Group on Post-COVID-19 Condition . A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. (2022) 22:e102&#x2013;7. doi: 10.1016/S1473-3099(21)00703-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Nittas V, Gao M, West EA, Ballouz T, Menges D, Wulf Hanson S, et al. . Long COVID through a public health Lens: an umbrella review. Public Health Rev. (2022) 43:1604501. doi: 10.3389/phrs.2022.1604501, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/phrs.2022.1604501</ArticleId><ArticleId IdType="pmc">PMC8963488</ArticleId><ArticleId IdType="pubmed">35359614</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul&#xe8; G, et al. . Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. (2021) 28:611.e9&#x2013;611.e16. doi: 10.1016/j.cmi.2021.11.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. . Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorrinolaringol. (2020) 277:2251&#x2013;61. doi: 10.1007/s00405-020-05965-1, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-05965-1</ArticleId><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng X, Deng Y, Dai Z, Meng Z. COVID-19 and anosmia: a review based on up-to-date knowledge. Am J Otolaryngol. (2020) 41:102581. doi: 10.1016/j.amjoto.2020.102581, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2020.102581</ArticleId><ArticleId IdType="pmc">PMC7265845</ArticleId><ArticleId IdType="pubmed">32563019</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Attributes and predictors of long COVID. Nat Med. (2021) 27:626&#x2013;31. doi: 10.1038/s41591-021-01292-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. (2021) 53:737&#x2013;54. doi: 10.1080/23744235.2021.1924397, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Lu S, Tang AF, Durstenfeld MS, Ho H-E, Goldberg SA, et al. . Markers of immune activation and inflammation in individuals with Postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis. (2021) 224:1839&#x2013;48. doi: 10.1093/infdis/jiab490, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsov AV, Rubtsova K, Kappler JW, Marrack P. Genetic and hormonal factors in female-biased autoimmunity. Autoimmun Rev. (2010) 9:494&#x2013;8. doi: 10.1016/j.autrev.2010.02.008, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2010.02.008</ArticleId><ArticleId IdType="pmc">PMC3171140</ArticleId><ArticleId IdType="pubmed">20144912</ArticleId></ArticleIdList></Reference><Reference><Citation>Taneja V. Sex Hormones Determine Immune Response. Front Immunol. (2018) 9:1931. doi: 10.3389/fimmu.2018.01931, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01931</ArticleId><ArticleId IdType="pmc">PMC6119719</ArticleId><ArticleId IdType="pubmed">30210492</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, et al. . Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 long haulers. Ann Clin Transl Neurol. (2021) 8:5: 1073&#x2013;85. doi: 10.1002/acn3.51350, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. . SARS-CoV-2 is associated with changes in brain structure in UK biobank. Nature. (2022) 604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomasson M, Voruz P, Cionca A, Jacot de Alc&#xe2;ntara I, Nuber-Champier A, Allali G, et al. . Markers of limbic system damage following SARS-CoV-2 infection. Brain Commun. (2023) 5:fcad177. doi: 10.1093/braincomms/fcad177, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcad177</ArticleId><ArticleId IdType="pmc">PMC10320753</ArticleId><ArticleId IdType="pubmed">37415776</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilarello BJ, Jacobson PT, Tervo JP, Waring NA, Gudis DA, Goldberg TE, et al. . Olfaction and neurocognition after COVID-19: a scoping review. Front Neurosci. (2023) 17:1198267. doi: 10.3389/fnins.2023.1198267</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2023.1198267</ArticleId><ArticleId IdType="pmc">PMC10339825</ArticleId><ArticleId IdType="pubmed">37457004</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman A, Jackson H, Hristov H, Isaacson RS, Saif N, Shetty T, et al. . Sex and gender driven modifiers of Alzheimer&#x2019;s: the role for estrogenic control across age, race, medical, and lifestyle risks. Front Aging Neurosci. (2019) 11:315. doi: 10.3389/fnagi.2019.00315, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2019.00315</ArticleId><ArticleId IdType="pmc">PMC6872493</ArticleId><ArticleId IdType="pubmed">31803046</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Y, Lu D, Liu L, Zhang H, Zhou Y. Olfactory dysfunction in Alzheimer&#x2019;s disease. Neuropsychiatr Dis Treat. (2016) 12:869&#x2013;75. doi: 10.2147/NDT.S104886, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S104886</ArticleId><ArticleId IdType="pmc">PMC4841431</ArticleId><ArticleId IdType="pubmed">27143888</ArticleId></ArticleIdList></Reference><Reference><Citation>Breit S, Kupferberg A, Rogler G, Hasler G. Vagus nerve as modulator of the brain-gut Axis in psychiatric and inflammatory disorders. Front Psych. (2018) 9:44. doi: 10.3389/fpsyt.2018.00044, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2018.00044</ArticleId><ArticleId IdType="pmc">PMC5859128</ArticleId><ArticleId IdType="pubmed">29593576</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaz B, Sinniger V, Pellissier S. Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation. J Physiol. (2016) 594:5781&#x2013;90. doi: 10.1113/JP271539, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP271539</ArticleId><ArticleId IdType="pmc">PMC5063949</ArticleId><ArticleId IdType="pubmed">27059884</ArticleId></ArticleIdList></Reference><Reference><Citation>Boon P, Moors I, De Herdt V, Vonck K. Vagus nerve stimulation and cognition. Seizure. (2006) 15:259&#x2013;63. doi: 10.1016/j.seizure.2006.02.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seizure.2006.02.014</ArticleId><ArticleId IdType="pubmed">16651013</ArticleId></ArticleIdList></Reference><Reference><Citation>Engineer ND, Kimberley TJ, Prudente CN, Dawson J, Tarver WB, Hays SA. Targeted Vagus nerve stimulation for rehabilitation after stroke. Front Neurosci. (2019) 13:280. doi: 10.3389/fnins.2019.00280, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00280</ArticleId><ArticleId IdType="pmc">PMC6449801</ArticleId><ArticleId IdType="pubmed">30983963</ArticleId></ArticleIdList></Reference><Reference><Citation>Howland RH. Vagus nerve stimulation. Curr Behav Neurosci Rep. (2014) 1:64&#x2013;73. doi: 10.1007/s40473-014-0010-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40473-014-0010-5</ArticleId><ArticleId IdType="pmc">PMC4017164</ArticleId><ArticleId IdType="pubmed">24834378</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong J, Fang J, Park J, Li S, Rong P. Treating depression with transcutaneous auricular Vagus nerve stimulation: state of the art and future perspectives. Front Psych. (2018) 9:20. doi: 10.3389/fpsyt.2018.00020, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2018.00020</ArticleId><ArticleId IdType="pmc">PMC5807379</ArticleId><ArticleId IdType="pubmed">29459836</ArticleId></ArticleIdList></Reference><Reference><Citation>Tornero C, Pastor E, Garzando M, Ordu&#xf1;a J, Forner MJ, Bocigas I, et al. . Non-invasive Vagus Nerve Stimulation for COVID-19: Results From a Randomized Controlled Trial (SAVIOR I). Front Neurol. (2022) 13:864. doi: 10.3389/fneur.2022.820864</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.820864</ArticleId><ArticleId IdType="pmc">PMC9028764</ArticleId><ArticleId IdType="pubmed">35463130</ArticleId></ArticleIdList></Reference><Reference><Citation>Uehara L, Corr&#xea;a JCF, Ritti R, Leite P, de Faria DRG, Pacheco-Barrios K, et al. . Transcutaneous auricular vagus nerve stimulation effects on inflammatory markers and clinical evolution of patients with COVID-19: a pilot randomized clinical trial. Expert Rev Med Devices. (2022) 19:915&#x2013;20. doi: 10.1080/17434440.2022.2154147, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17434440.2022.2154147</ArticleId><ArticleId IdType="pubmed">36540947</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbanck C. (2021). Transcutaneous Auricular Vagus Nerve Stimulation (tVNS) can Reverse the Manifestations of the Long-COVID Syndrome: A Pilot Study. Available at: https://www.semanticscholar.org/paper/Transcutaneous-Auricular-Vagus-Nerve-Stimulation-of-Verbanck-Corazza/8a39f3f621d92576369d988a59bf617e3935cf36</Citation></Reference><Reference><Citation>Yokota H, Edama M, Hirabayashi R, Sekine C, Otsuru N, Saito K, et al. . Effects of stimulus frequency, intensity, and sex on the autonomic response to transcutaneous Vagus nerve stimulation. Brain Sci. (2022) 12:1038. doi: 10.3390/brainsci12081038, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12081038</ArticleId><ArticleId IdType="pmc">PMC9405815</ArticleId><ArticleId IdType="pubmed">36009101</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. . Risk factors associated with post&#x2212;COVID-19 condition: a systematic review and Meta-analysis. JAMA Intern Med. (2023) 183:566&#x2013;80. doi: 10.1001/jamainternmed.2023.0750, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, et al. . Missing value estimation methods for DNA microarrays. Bioinformatics. (2001) 17:520&#x2013;5. doi: 10.1093/bioinformatics/17.6.520</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/17.6.520</ArticleId><ArticleId IdType="pubmed">11395428</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Keung JW, Sarro F, Li Y-F, Yu YT, Chan WK, et al. . Cross-validation based K nearest neighbor imputation for software quality datasets: an empirical study. J Syst Softw. (2017) 132:226&#x2013;52. doi: 10.1016/j.jss.2017.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2017.07.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap JYY, Keatch C, Lambert E, Woods W, Stoddart PR, Kameneva T. Critical review of transcutaneous Vagus nerve stimulation: challenges for translation to clinical practice. Front Neurosci. (2020) 14:284. doi: 10.3389/fnins.2020.00284</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00284</ArticleId><ArticleId IdType="pmc">PMC7199464</ArticleId><ArticleId IdType="pubmed">32410932</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang J, Egorova N, Rong P, Liu J, Hong Y, Fan Y, et al. . Early cortical biomarkers of longitudinal transcutaneous vagus nerve stimulation treatment success in depression. NeuroImage Clin. (2017) 14:105&#x2013;11. doi: 10.1016/j.nicl.2016.12.016, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.12.016</ArticleId><ArticleId IdType="pmc">PMC5279909</ArticleId><ArticleId IdType="pubmed">28180068</ArticleId></ArticleIdList></Reference><Reference><Citation>Vonck K, De Herdt V, Bosman T, Dedeurwaerdere S, Van Laere K, Boon P. Thalamic and limbic involvement in the mechanism of action of vagus nerve stimulation, a SPECT study. Seizure. (2008) 17:699&#x2013;706. doi: 10.1016/j.seizure.2008.05.001, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seizure.2008.05.001</ArticleId><ArticleId IdType="pubmed">18556220</ArticleId></ArticleIdList></Reference><Reference><Citation>Clancy JA, Mary DA, Witte KK, Greenwood JP, Deuchars SA, Deuchars J. Non-invasive Vagus nerve stimulation in healthy humans reduces sympathetic nerve activity. Brain Stimul. (2014) 7:871&#x2013;7. doi: 10.1016/j.brs.2014.07.031, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2014.07.031</ArticleId><ArticleId IdType="pubmed">25164906</ArticleId></ArticleIdList></Reference><Reference><Citation>Carreno FR, Frazer A. Vagal nerve stimulation for treatment-resistant depression. Neurotherapeutics. (2017) 14:716&#x2013;27. doi: 10.1007/s13311-017-0537-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-017-0537-8</ArticleId><ArticleId IdType="pmc">PMC5509631</ArticleId><ArticleId IdType="pubmed">28585221</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao Y, Guo X, Luo M, Li S, Liu A, Zhao Y, et al. . Effect of transcutaneous Vagus nerve stimulation at auricular concha for insomnia: a randomized clinical trial. Evid Based Complement Alternat Med. (2020) 2020:e6049891: 1&#x2013;7. doi: 10.1155/2020/6049891, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/6049891</ArticleId><ArticleId IdType="pmc">PMC7429019</ArticleId><ArticleId IdType="pubmed">32831871</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C-H, Giuliani F. The role of inflammation in depression and fatigue. Front Immunol. (2019) 10:1696. doi: 10.3389/fimmu.2019.01696, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01696</ArticleId><ArticleId IdType="pmc">PMC6658985</ArticleId><ArticleId IdType="pubmed">31379879</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges U, Knops L, Laborde S, Klatt S, Raab M. Transcutaneous Vagus nerve stimulation May enhance only specific aspects of the Core executive functions. A randomized crossover trial. Front Neurosci. (2020) 14:523. doi: 10.3389/fnins.2020.00523, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00523</ArticleId><ArticleId IdType="pmc">PMC7262369</ArticleId><ArticleId IdType="pubmed">32523510</ArticleId></ArticleIdList></Reference><Reference><Citation>Jongkees BJ, Immink MA, Finisguerra A, Colzato LS. Transcutaneous Vagus nerve stimulation (tVNS) enhances response selection during sequential action. Front Psychol. (2018) 9:1159. doi: 10.3389/fpsyg.2018.01159, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2018.01159</ArticleId><ArticleId IdType="pmc">PMC6043681</ArticleId><ArticleId IdType="pubmed">30034357</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellaro R, van Leusden JWR, Tona K-D, Verkuil B, Nieuwenhuis S, Colzato LS. Transcutaneous Vagus nerve stimulation enhances post-error slowing. J Cogn Neurosci. (2015) 27:2126&#x2013;32. doi: 10.1162/jocn_a_00851, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1162/jocn_a_00851</ArticleId><ArticleId IdType="pubmed">26226074</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs HIL, Riphagen JM, Razat CM, Wiese S, Sack AT. Transcutaneous vagus nerve stimulation boosts associative memory in older individuals. Neurobiol Aging. (2015) 36:1860&#x2013;7. doi: 10.1016/j.neurobiolaging.2015.02.023, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.02.023</ArticleId><ArticleId IdType="pubmed">25805212</ArticleId></ArticleIdList></Reference><Reference><Citation>Jandackova V, Vasendova V, Jackowska M, Koenig J. The effect of long-term non-invasive vagus nerve stimulation on cognitive performance: results from a randomized placebo controlled trial. Brain Stimul. (2023) 16:6. doi: 10.1016/j.brs.2023.03.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2023.03.028</ArticleId></ArticleIdList></Reference><Reference><Citation>Aniwattanapong D, List JJ, Ramakrishnan N, Bhatti GS, Jorge R. Effect of Vagus nerve stimulation on attention and working memory in neuropsychiatric disorders: a systematic review. Neuromodulation. (2022) 25:343&#x2013;55. doi: 10.1016/j.neurom.2021.11.009, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurom.2021.11.009</ArticleId><ArticleId IdType="pubmed">35088719</ArticleId></ArticleIdList></Reference><Reference><Citation>Broncel A, Bocian R, K&#x142;os-Wojtczak P, Kulbat-Warycha K, Konopacki J. Vagal nerve stimulation as a promising tool in the improvement of cognitive disorders. Brain Res Bull. (2020) 155:37&#x2013;47. doi: 10.1016/j.brainresbull.2019.11.011, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2019.11.011</ArticleId><ArticleId IdType="pubmed">31790720</ArticleId></ArticleIdList></Reference><Reference><Citation>Giraudier M, Ventura-Bort C, Weymar M. Transcutaneous Vagus nerve stimulation (tVNS) improves high-confidence recognition memory but not emotional word processing. Front Psychol. (2020) 11:1276. doi: 10.3389/fpsyg.2020.01276, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2020.01276</ArticleId><ArticleId IdType="pmc">PMC7363946</ArticleId><ArticleId IdType="pubmed">32733306</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas-Caballero M, Warming H, Walker R, Holmes C, Cruickshank G, Patel B. Vagus nerve stimulation as a potential therapy in early Alzheimer&#x2019;s disease: a review. Front Hum Neurosci. (2022) 16:866434. doi: 10.3389/fnhum.2022.866434, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2022.866434</ArticleId><ArticleId IdType="pmc">PMC9098960</ArticleId><ArticleId IdType="pubmed">35572001</ArticleId></ArticleIdList></Reference><Reference><Citation>George MS, Ward HE, Ninan PT, Pollack M, Nahas Z, Anderson B, et al. . A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. (2008) 1:112&#x2013;21. doi: 10.1016/j.brs.2008.02.001, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2008.02.001</ArticleId><ArticleId IdType="pubmed">20633378</ArticleId></ArticleIdList></Reference><Reference><Citation>Grolaux PJD. Transcutaneous Vagus nerve stimulation in private healthcare center: a small-scale investigation targeting anxiety, irritable bowel syndrome and chronic pain. J Neurol Neuromed. (2019) 4:7&#x2013;22. doi: 10.29245/2572.942X/2019/5.1251</Citation><ArticleIdList><ArticleId IdType="doi">10.29245/2572.942X/2019/5.1251</ArticleId></ArticleIdList></Reference><Reference><Citation>Hein E, Nowak M, Kiess O, Biermann T, Bayerlein K, Kornhuber J, et al. . Auricular transcutaneous electrical nerve stimulation in depressed patients: a randomized controlled pilot study. J Neural Transm. (2013) 120:821&#x2013;7. doi: 10.1007/s00702-012-0908-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-012-0908-6</ArticleId><ArticleId IdType="pubmed">23117749</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D, Wang J, Yuan Y. Effects of transcranial direct current stimulation on naming and cortical excitability in stroke patients with aphasia. Neurosci Lett. (2015) 589:115&#x2013;20. doi: 10.1016/j.neulet.2015.01.045, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2015.01.045</ArticleId><ArticleId IdType="pubmed">25603474</ArticleId></ArticleIdList></Reference><Reference><Citation>Badran BW, Huffman SM, Dancy M, Austelle CW, Bikson M, Kautz SA, et al. . A pilot randomized controlled trial of supervised, at-home, self-administered transcutaneous auricular vagus nerve stimulation (taVNS) to manage long COVID symptoms. Bioelectron Med. (2022) 8:13. doi: 10.1186/s42234-022-00094-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42234-022-00094-y</ArticleId><ArticleId IdType="pmc">PMC9402278</ArticleId><ArticleId IdType="pubmed">36002874</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimpianu C-L, Strube W, Falkai P, Palm U, Hasan A. Vagus nerve stimulation in psychiatry: a systematic review of the available evidence. J Neural Transm. (2017) 124:145&#x2013;58. doi: 10.1007/s00702-016-1642-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-016-1642-2</ArticleId><ArticleId IdType="pubmed">27848034</ArticleId></ArticleIdList></Reference><Reference><Citation>Vonck K, Raedt R, Naulaerts J, De Vogelaere F, Thiery E, Van Roost D, et al. . Vagus nerve stimulation&#x2026;25 years later! What do we know about the effects on cognition? Neurosci Biobehav Rev. (2014) 45:63&#x2013;71. doi: 10.1016/j.neubiorev.2014.05.005, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2014.05.005</ArticleId><ArticleId IdType="pubmed">24858008</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Zhang J, Guo C, He J, Zhang S, Wang Y, et al. . The efficacy and safety of transcutaneous auricular vagus nerve stimulation in patients with mild cognitive impairment: a double blinded randomized clinical trial. Brain Stimul. (2022) 15:1405&#x2013;14. doi: 10.1016/j.brs.2022.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2022.09.003</ArticleId><ArticleId IdType="pubmed">36150665</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>